Prof. Tozzi discusses about Aperto® drug-coated balloon as a “first-line” treatment of neointimal hyperplasia in ArterioVenous Fistula (AVF) lesions and CVS

Prof. Matteo Tozzi (Varese, Italy) spoke to Vascular News at Charing Cross 2023 meeting held in London (England) about the variety of vascular access complications and their treatment options.

In this video-interview, Prof. Tozzi commented as fantastic the clinical outcomes of Aperto^® DCB in his recent analysis, in which more than 600 Aperto^® DCB have been used in ArteriousVenous Fistula (AVF) and AVG, including a large number of Central Vein Stenosis (CVS).